Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

January 12, 2022 by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing.

“I’ve heard from so many people who are waiting in long lines and going from pharmacy to pharmacy trying to find a test, or who are giving up on getting tested because tests are unavailable or cost too much,” Sen. Patty Murray, D-Wash., said Tuesday during a Senate hearing to discuss federal perspectives on COVID-19.

There are currently 16 authorized home diagnostic tests, which consist of 12 antigen tests and four molecular polymerase chain reaction, or PCR tests to detect a virus’ genetic material. 

Under the new White House policy, up to eight COVID home testing kits per month can be purchased through insurance for free, or an individual can submit a claim to an insurance provider for reimbursement. However, there are no monthly limits for how many PCR and rapid tests can be ordered by a health provider, which will also be fully covered by insurance.

The Biden administration expects 300 million tests to be available by February 2022. They hope to accomplish this by streamlining efforts of the FDA’s regulatory pathway to bring them into the US market.

While the tall order of rapid tests may help to address the current shortage of tests available on the market, there are new concerns about the reliability of antigen rapid tests in detecting early omicron infection.

The U.S. Food and Drug Administration made recent updates to their testing recommendations after reviewing preliminary evidence of antigen tests and patient samples of those infected with the omicron variant.

“Early data suggests that antigen tests do detect the omicron variant but may have reduced sensitivity,” said the FDA in the update. 

“Antigen tests are generally less sensitive and less likely to pick up very early infections compared to molecular tests,” the agency continues in the update.

The agency recommends that any individual who tests negative with an antigen test but suspect they have COVID-19 should follow-up with a molecular testing to determine if they have COVID-19 infection.

Researchers from Yale University also published recent findings that an at-home rapid antigen test may not be able to detect the omicron variant before infected people transmit it to others. 

“We need to reconsider our testing options. Testing strategies can’t just be a rigid thing. What applies for one variant doesn’t apply to others,” said Anne Wyllie, research scientist at Yale School of Public Health, in a phone call with The Well News. 

“These were observations made in early to mid-December, and we knew the country was relying on these tests to travel…what alarm bells do you ring?” questioned Wyllie.

“One needs to be sure that what we are seeing is an actual phenomenon, but knowing in the meantime the delay is going to cause continued spread,” continued Wyllie.

From Dec. 1- Dec. 31, Wyllie and researchers observed 30 fully vaccinated and boosted individuals in New York, Los Angeles, and San Francisco who were enrolled in employer testing programs requiring daily testing using both nasal rapid antigen tests and saliva PCR tests. 

The findings showed that during the initial days of infection while the PCR tests produced a positive result, all of the antigen tests reflected a false-negative result. 

According to the research, four of the infected individuals transmitted the virus to others before the rapid antigen test produced a positive result.

“There’s probably been hundreds or thousands of missed cases out there as the country relied on antigen tests to travel around the country during the holidays and see their families,” said Wyllie.

The study raises the issue with the reliability of rapid testing during the initial stages of infection but also points out potential issues that might occur with employer testing programs. 

“The policy implication is that rapid antigen tests may not be as fit-for-purpose in routine workplace screening to prevent asymptomatic spread of omicron, compared to prior variants,” said Wyllie.

The White House has also announced plans to launch a website that would make 500 million at-home tests available by mail, provide 50 million at-home tests to community health centers and rural clinics, and create surge testing sites.

However, Wyllie said that hopefully the need for rapid antigen saliva test or oral swab-based tests will be addressed as soon as possible. 

“I hope manufacturers of rapid antigen tests are actually going to do the responsible thing and validate the test for oral swabs. Otherwise, we just need more clear messaging from the likes of the CDC, from the White House, from anyone else in that position where they say you need to listen to symptoms and consider your exposures, and that if you had those you know you can’t always rely on that negative antigen test result,” said Wyllie.

Alexa can be reached at [email protected] 

A+
a-
  • Antigen Rapid Tests
  • omicron
  • Patty Murray
  • White House
  • In The News

    Health

    Voting

    In The News

    US Changes How it Categorizes People by Race and Ethnicity. It's the First Revision in 27 Years

    ORLANDO, Fla. (AP) — For the first time in 27 years, the U.S. government is changing how it categorizes people by race and... Read More

    ORLANDO, Fla. (AP) — For the first time in 27 years, the U.S. government is changing how it categorizes people by race and ethnicity, an effort that federal officials believe will more accurately count residents who identify as Hispanic and of Middle Eastern and North African heritage. The revisions... Read More

    March 28, 2024
    by Dan McCue
    Vice President Harris Rolls Out First Government-Wide Policy to Mitigate AI Risks

    WASHINGTON — Vice President Kamala Harris on Wednesday rolled out the Biden administration’s first government-wide policy intended to mitigate the... Read More

    WASHINGTON — Vice President Kamala Harris on Wednesday rolled out the Biden administration’s first government-wide policy intended to mitigate the risks associated with artificial intelligence while still enabling its use to advance the public interest. The new policy, which is being issued through the White House... Read More

    March 27, 2024
    by TWN Staff
    Rep. Cleaver New Co-Chair of House Renewable Energy and Energy Efficiency Caucus

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency... Read More

    WASHINGTON — Rep. Emanuel Cleaver II, D-Mo., is the new Democratic co-chair of the House Renewable Energy and Energy Efficiency Caucus. He was invited to serve as co-chair by Sens. Jack Reed, D-R.I., and Mike Crapo, R-Idaho, the co-chairs of the Senate Renewable Energy and Energy... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    March 27, 2024
    by Dan McCue
    New Dem Chair Kuster Announces Retirement Following 2024 Election

    CONCORD, N.H. — Rep. Annie Kuster, D-N.H., who, among other things, is the current chair of the New Democrat Coalition... Read More

    CONCORD, N.H. — Rep. Annie Kuster, D-N.H., who, among other things, is the current chair of the New Democrat Coalition in the House, revealed Wednesday that she will not seek reelection to Congress this year. In a lengthy statement released by her office, Kuster gives no... Read More

    News From The Well
    scroll top